Response to Letter to the Editor: Fully COVID ‐19 Vaccinated Status Enhanced the Efficacy of Immune Checkpoint Inhibitors in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma

View at publisher
Authors: Chien-Chung Wang, Chih‐Chun Wang, Chuan‐Chien Yang, Tzer‐Zen Hwang, Ching‐Feng Lien, Yu-Chen Shih, Shyh‐An Yeh, Meng-Che Hsieh
Cited by: 0

Abstract

Data sharing is not applicable to this article as no datasets were generated or analyzed during the current study.

Fields of Study & Subjects

Cancer Immunotherapy and Biomarkers Head and Neck Cancer Studies COVID-19 and healthcare impacts

Publication details

Journal / source
Head & Neck
Volume
48
Issue
4
Pages
1143–1144
Publication date
30 January 2026
Language
EN